VastCon Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $25K
Latest Deal Amount
  • Investors
  • 2

VastCon General Information


Operator of a cancer diagnostics company designed to develop colorectal cancer screening test. The company's technology is based on the discovery of two biomarkers that are present in high concentrations in the peripheral blood of CRC patients, enabling patients to avail a cost effective, highly sensitivity and reliability test for detecting colorectal cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Medical Supplies
Other Industries
Other Healthcare Services
Primary Office
  • 23 Edington Point
  • Winnipeg, Manitoba R3Y 0A2
  • Canada
+1 (204) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VastCon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 14-Feb-2018 $25K 0000 Completed Startup
2. Grant 20-Jun-2013 00.000 Completed Startup
1. Angel (individual) Completed Startup

VastCon Executive Team (2)

Name Title Board Seat Contact Info
Anuraag Shrivastav Co-Founder & President
Shailly Varma Shrivastav Co-Founder & Board Member

VastCon Board Members (1)

Name Representing Role Since
Shailly Varma Shrivastav VastCon Co-Founder & Board Member 000 0000

VastCon Investors (2)

To view VastCon‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate Manitoba Accelerator/Incubator 000 0000 000000 0
Valhalla Private Capital Angel Group Minority 000 0000 000000 0

Ready to get started?

Request a free trial